ADIPOQ and hydrops fetalis: The increase of the ADPN receptors in cardiac tissue from HF children after VAD implant could counterbalance the phenomenon of “ADPN resistance” hypothesized for HF patients, leading to a recovery of the ADPN cardioprotective effects.